Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q3 FY23 results · Oct–Dec 2022
Wockhardt reported revenue from operations of ₹699.00 crore (down 18.1% from Q3 FY22) and net loss of ₹102.00 crore for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 699.00 | 853.89 | −18.1% | 679.00 | +2.9% |
| Other income | 2.00 | 2.05 | −2.4% | 57.00 | −96.5% |
| Total income | 701.00 | 855.94 | −18.1% | 736.00 | −4.8% |
| Profit before tax | (105.00) | (28.56) | Loss widened | (230.00) | Loss narrowed |
| Net profit for the period | (102.00) | 1.77 | Turned loss | (207.00) | Loss narrowed |
| Attributable to shareholders of the company | (96.00) | (6.78) | Loss widened | (189.00) | Loss narrowed |
| EPS, basic (₹) | (6.62) | (0.61) | not comparable | (13.15) | Loss narrowed |
| Net margin (%) | -14.6 | 0.2 | -30.5 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 282.00 | 308.61 | −8.6% | 258.00 | +9.3% |
| Other income | 18.00 | 3.01 | +498.0% | 29.00 | −37.9% |
| Total income | 300.00 | 311.62 | −3.7% | 287.00 | +4.5% |
| Profit before tax | (55.00) | (103.99) | Loss narrowed | (115.00) | Loss narrowed |
| Net profit for the period | (55.00) | (67.12) | Loss narrowed | (75.00) | Loss narrowed |
| EPS, basic (₹) | (3.81) | (6.06) | not comparable | (5.17) | Loss narrowed |
| Net margin (%) | -19.5 | -21.7 | -29.1 |
Consolidated
- Filed with BSE
- 13 Feb 2023, 17:48 IST
- Board meeting
- 13 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Feb 2023, 17:48 IST
- Board meeting
- 13 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE